These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34768178)

  • 21. Incidence of sudden unexpected death in epilepsy in children is similar to adults.
    Keller AE; Whitney R; Li SA; Pollanen MS; Donner EJ
    Neurology; 2018 Jul; 91(2):e107-e111. PubMed ID: 29884734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment.
    Bishop KI; Isquith PK; Gioia GA; Knupp KG; Scheffer IE; Nabbout R; Specchio N; Sullivan J; Auvin S; Helen Cross J; Guerrini R; Farfel G; Galer BS; Gammaitoni AR
    Epilepsy Behav; 2023 Jan; 138():108994. PubMed ID: 36463826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenfluramine responder analyses and numbers needed to treat: Translating epilepsy trial data into clinical practice.
    Sullivan J; Perry MS; Wheless JW; Galer B; Gammaitoni A
    Eur J Paediatr Neurol; 2021 Mar; 31():10-14. PubMed ID: 33540241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study.
    Aurlien D; Larsen JP; Gjerstad L; Taubøll E
    Epilepsia; 2012 Feb; 53(2):258-66. PubMed ID: 22126371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study.
    Specchio N; Pietrafusa N; Doccini V; Trivisano M; Darra F; Ragona F; Cossu A; Spolverato S; Battaglia D; Quintiliani M; Luigia Gambardella M; Rosati A; Mei D; Granata T; Dalla Bernardina B; Vigevano F; Guerrini R
    Epilepsia; 2020 Nov; 61(11):2405-2414. PubMed ID: 32945537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality in Dravet syndrome: A review.
    Shmuely S; Sisodiya SM; Gunning WB; Sander JW; Thijs RD
    Epilepsy Behav; 2016 Nov; 64(Pt A):69-74. PubMed ID: 27732919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden unexpected death in a mouse model of Dravet syndrome.
    Kalume F; Westenbroek RE; Cheah CS; Yu FH; Oakley JC; Scheuer T; Catterall WA
    J Clin Invest; 2013 Apr; 123(4):1798-808. PubMed ID: 23524966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome.
    Schoonjans AS; Ceulemans B
    Expert Rev Neurother; 2022 May; 22(5):351-364. PubMed ID: 33455486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome.
    Li J; Nelis M; Sourbron J; Copmans D; Lagae L; Cabooter D; de Witte PAM
    Neurochem Res; 2021 Sep; 46(9):2249-2261. PubMed ID: 34041623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.
    Gil-Nagel A; Sullivan J; Ceulemans B; Wirrell E; Devinsky O; Nabbout R; Knupp KG; Scott Perry M; Polster T; Davis R; Lock M; Cortes RM; Gammaiton AR; Farfel G; Galer BS; Agarwal A
    Epilepsy Behav; 2021 Sep; 122():108212. PubMed ID: 34352670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.
    Schoonjans AS; Marchau F; Paelinck BP; Lagae L; Gammaitoni A; Pringsheim M; Keane MG; Ceulemans B
    Curr Med Res Opin; 2017 Oct; 33(10):1773-1781. PubMed ID: 28704161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials.
    Tomson T; Hirsch LJ; Friedman D; Bester N; Hammer A; Irizarry M; Ishihara L; Krishen A; Spaulding T; Wamil A; Leadbetter R
    Epilepsia; 2013 Jan; 54(1):135-40. PubMed ID: 23030403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenfluramine treatment for dravet syndrome: Real-world benefits on quality of life from the caregiver perspective.
    Jensen MP; Gammaitoni AR; Galer BS; Salem R; Wilkie D; Amtmann D
    Epilepsy Res; 2022 Sep; 185():106976. PubMed ID: 35843016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends and autopsy findings of SUDEP based on medico-legal investigations in the United States.
    Cihan E; Devinsky O; Hesdorffer DC; Brandsoy M; Li L; Fowler DR; Graham JK; Karlovich MW; Yang JE; Keller AE; Donner EJ; Friedman D
    Neurology; 2020 Aug; 95(7):e867-e877. PubMed ID: 32636323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenfluramine below the age of 2 years in Dravet syndrome: What about safety and efficacy?
    Pietrafusa N; Trivisano M; Casellato S; Correale C; Cappelletti S; De Liso P; Onida I; Sotgiu S; Butera A; Specchio N; Vigevano F
    Epilepsia; 2024 Feb; 65(2):e7-e13. PubMed ID: 38065833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epilepsy and seizure-related deaths: Mortality statistics do not tell the complete story.
    Panelli RJ; O'Brien TJ
    Epilepsy Behav; 2019 Sep; 98(Pt A):266-272. PubMed ID: 31408827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis.
    Tabaee Damavandi P; Fabin N; Giossi R; Matricardi S; Del Giovane C; Striano P; Meletti S; Brigo F; Trinka E; Lattanzi S
    Neurol Ther; 2023 Apr; 12(2):669-686. PubMed ID: 36853503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
    Maguire MJ; Jackson CF; Marson AG; Nolan SJ
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011792. PubMed ID: 27434597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroencephalography characteristics related to risk of sudden unexpected death in epilepsy in patients with Dravet syndrome.
    Kim JY; Shin J; Kim L; Kim SH
    Front Neurol; 2023; 14():1222721. PubMed ID: 37745659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden unexpected death in epilepsy: a review of incidence and risk factors.
    Tomson T; Walczak T; Sillanpaa M; Sander JW
    Epilepsia; 2005; 46 Suppl 11():54-61. PubMed ID: 16393182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.